KAZIA THERAPEUTICS LTD Logo

KAZIA THERAPEUTICS LTD

Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.

KZIA | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
THREE INTERNATIONAL TOWERS LEVEL 24,, 2000 SYDNEY NSW

Description

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company engaged in the development of innovative drugs for cancer. The company's lead program is paxalisib, a small molecule inhibitor of the PI3K/AKT/mTOR pathway designed to cross the blood-brain barrier, which is being investigated for various forms of brain cancer. Its development pipeline also includes EVT801, a selective VEGFR3 inhibitor being studied for its potential to block the growth of blood and lymphatic vessels that support tumor growth. The company focuses on addressing cancers with high unmet medical needs through its portfolio of targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 18:27
424B3
English 208.7 KB
2025-12-23 18:27
424B3
English 173.3 KB
2025-12-23 17:06
424B3
English 153.5 KB
2025-12-23 17:06
424B3
English 177.3 KB
2025-12-23 01:15 English 5.3 KB
2025-12-23 01:15 English 5.3 KB
2025-12-19 22:46
POS AM
English 203.6 KB
2025-12-19 22:46
POS AM
English 179.9 KB
2025-12-19 22:45
F-1/A
English 198.5 KB
2025-12-19 22:44
F-1
English 444.6 KB
2025-12-19 22:01
6-K
English 8.9 KB
2025-12-18 20:21 English 9.4 KB
2025-12-10 22:11
6-K
English 19.5 KB
2025-12-05 22:05
6-K
English 12.0 KB
2025-12-02 22:05
6-K
English 192.4 KB

Automate Your Workflow. Get a real-time feed of all KAZIA THERAPEUTICS LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAZIA THERAPEUTICS LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAZIA THERAPEUTICS LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DG INNOVATE PLC Logo
Develops sustainable technologies for electric mobility and energy storage solutions.
United Kingdom
DGI
Dianthus Therapeutics, Inc. /DE/ Logo
Clinical-stage biotech developing therapies for severe autoimmune diseases.
United States of America
DNTH
Dogwood Therapeutics, Inc. Logo
A biotech company developing novel therapeutics for pain and neuropathy.
United States of America
DWTX
DreamCIS INC. Logo
Contract research organization for pharma, biotech, and medical device industries.
South Korea
223250
DT&CRO CO., Ltd. Logo
A full-service CRO providing non-clinical and clinical studies for various industries.
South Korea
383930
D.Western Therapeutics Institute, Inc. Logo
Biotechnology firm developing drugs from a proprietary protein kinase inhibitor library.
Japan
4576
Ectin Research AB Logo
Pharmaceutical company developing novel oncology treatments, with a lead drug in trials.
Sweden
ECTIN B
EdgeLab S.p.A. Logo
Designs and manufactures marine and underwater solutions, including AUVs and robotics.
Italy
ELB
Editas Medicine, Inc. Logo
A clinical-stage genome editing company developing CRISPR medicines for serious diseases.
United States of America
EDIT
Eledon Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for organ and autoimmune diseases.
United States of America
ELDN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.